Home > Insider Trading > Filing (0001022079-20-000071)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1022079	Quest Diagnostics Inc	DGX	Services-Medical Laboratories (8071)	161387862

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1142624	H Stephen Rusckowski	500 Plaza Drive Secaucus NJ 07094	Chairman, Ceo And President	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-03-10	25,085	$106.46	251,645	No	4	A	Direct
Common Stock	Disposition	2020-03-10	13,898	$106.46	237,747	No	4	F	Direct
Common Stock	Acquisiton	2020-03-10	100	$71.17	237,847	No	4	M	Direct
Common Stock	Disposition	2020-03-10	100	$112.19	237,747	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	F	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualifed Stock Option (right to buy)	Disposition	2020-03-10	100	$71.17	100	$71.17

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
11,717		2025-02-23	No	4	M	Direct

Footnotes

Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 18, 2017, approved in accordance with the requirements of Rule 16b-3(d).
Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award.
This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on February 4, 2020.
The options vested in three annual installments beginning with the first on February 23, 2016, the second on February 23, 2017 and the final on February 23, 2018.